Chapter 1. Introduction


1.1. Report description and scope

1.2. Research scope

1.3. Research methodology


1.3.1. Market research process

1.3.2. Market research methodology

Chapter 2. Executive Summary


2.1. Global myocardial infarction treatment market, 2016 2022 (USD Billion)

2.2. Global myocardial infarction treatment market : Snapshot

Chapter 3. Myocardial infarction treatment Market Dynamics


3.1. Introduction

3.2. Market drivers


3.2.1. Global myocardial infarction treatment market drivers: Impact analysis

3.2.2. Rising incidences of cardiovascular diseases

3.2.3. Sedentary lifestyle

3.3. Market restraints


3.3.1. Global myocardial infarction treatment market restraints: Impact analysis

3.3.2. High cost of research and development

3.4. Opportunities


3.4.1. Adoption of advanced technology

3.5. Porters five forces analysis


3.5.1. Bargaining power of suppliers

3.5.2. Bargaining power of buyers

3.5.3. Threat from new entrants

3.5.4. Threat from new substitutes

3.5.5. Degree of competition

3.6. Market attractiveness analysis


3.6.1. Market attractiveness analysis, by product type

3.6.2. Market attractiveness analysis, by distribution channel

3.6.3. Market attractiveness analysis, by regional segment

Chapter 4. Global Myocardial infarction treatment Market Competitive Landscape


4.1. Company Market Share Analysis


4.1.1. Global myocardial infarction treatment market: company market share, 2015

4.2. Strategic Development


4.2.1. Acquisitions Mergers

4.2.2. New Therapy Launch

4.2.3. Agreements, Partnerships, Collaborations and Joint Ventures

4.2.4. Research and Development, Therapy and Regional Expansion

4.3. Price Trend Analysis

4.4. Therapy Portfolio

4.5. Patent Analysis (2011-2016)


4.5.1. Patent Trend

4.5.2. Patent Share by company

4.5.3. By Region

Chapter 5. Global Myocardial infarction treatment Market Product Type Segment Analysis


5.1. Global myocardial infarction treatment market: Therapy overview


5.1.1. Global myocardial infarction treatment market revenue share, by Product type, 2014 and 2022

5.2. Antiplatelet agents


5.2.1. Global Antiplatelet agents market, 2014 2022 (USD Billion)

5.3. Glycoprotein IIb/IIIa inhibitors


5.3.1. Global Glycoprotein IIb/IIIa inhibitors market, 2014 2022 (USD Billion)

5.4. Antithrombotic agents


5.4.1. Global Antithrombotic agents market, 2014 2022 (USD Billion)

5.5. Beta-adrenergic blockers


5.5.1. Global Beta-adrenergic blockers market, 2014 2022 (USD Billion)

5.6. Vasodilators


5.6.1. Global Vasodilators market, 2014 2022 (USD Billion)

5.7. Angiotensin-Converting Enzyme (ACE) inhibitors


5.7.1. Global Angiotensin-Converting Enzyme (ACE) inhibitors market, 2014 2022 (USD Billion)

5.8. Angiotensin-Receptor blockers


5.8.1. Global Angiotensin-Receptor blockers market, 2014 2022 (USD Billion)

5.9. Analgesics


5.9.1. Global Analgesics market, 2014 2022 (USD Billion)

5.10. Thrombolytics


5.10.1. Global Thrombolytics market, 2014 2022 (USD Billion)

Chapter 6. Global Myocardial Infarction Treatment Market Distribution Channel Segment Analysis


6.1. Global myocardial infarction treatment market: Distribution channel overview


6.1.1. Global myocardial infarction treatment market revenue share, by distribution channel, 2014 and 2022

6.2. Hospitals


6.2.1. Global myocardial infarction treatment market for Hospitals, 2014 2022 (USD Billion)

6.3. Hospital Pharmacies


6.3.1. Global myocardial infarction treatment market for Hospital Pharmacies, 2014 2022 (USD Billion)

6.4. Drug Stores


6.4.1. Global myocardial infarction treatment market for Drug Stores, 2014 2022 (USD Billion)

6.5. Online Drug Stores


6.5.1. Global myocardial infarction treatment market for Online Drug Stores, 2014 2022 (USD Billion)

Chapter 7. Global Myocardial infarction treatment Market Regional Segment Analysis


7.1. Global myocardial infarction treatment market: Regional overview


7.1.1. Global myocardial infarction treatment market revenue share, by region, 2014 and 2022

7.2. North America


7.2.1. North America myocardial infarction treatment market revenue, by Product type, 2014 2022 (USD Billion)

7.2.2. North America myocardial infarction treatment market revenue, by distribution channel, 2014 2022 (USD Billion)

7.2.3. U.S.


7.2.3.1. U.S. myocardial infarction treatment market revenue, by Product type, 2014 2022 (USD Billion)

7.2.3.2. U.S. myocardial infarction treatment market revenue, by distribution channel, 2014 2022 (USD Billion)

7.3. Europe


7.3.1. Europe myocardial infarction treatment market revenue, Product type, 2014 2022 (USD Billion)

7.3.2. Europe myocardial infarction treatment market revenue, by Distribution channel, 2014 2022 (USD Billion)

7.3.3. Germany


7.3.3.1. Germany myocardial infarction treatment market revenue, by Product type, 2014 2022 (USD Billion)

7.3.3.2. Germany myocardial infarction treatment market revenue, by Distribution channel, 2014 2022 (USD Billion)

7.3.4. France


7.3.4.1. France myocardial infarction treatment market revenue, by Product type, 2014 2022 (USD Billion)

7.3.4.2. France myocardial infarction treatment market revenue, by Distribution channel, 2014 2022 (USD Billion)

7.3.5. UK


7.3.5.1. UK myocardial infarction treatment market revenue, by Product type, 2014 2022 (USD Billion)

7.3.5.2. UK myocardial infarction treatment market revenue, by Distribution channel, 2014 2022 (USD Billion)

7.4. Asia Pacific


7.4.1. Asia Pacific myocardial infarction treatment market revenue, by Product type, 2014 2022, (USD Billion)

7.4.2. Asia Pacific myocardial infarction treatment market revenue, by Distribution channel, 2014 2022, (USD Billion)

7.4.3. China


7.4.3.1. China myocardial infarction treatment market revenue, by Product type, 2014 2022(USD Billion)

7.4.3.2. China myocardial infarction treatment market revenue, by Distribution channel, 2014 2022(USD Billion)

7.4.4. Japan


7.4.4.1. Japan myocardial infarction treatment market revenue, by Product type, 2014 2022 (USD Billion)

7.4.4.2. Japan myocardial infarction treatment market revenue, by Distribution channel, 2014 2022 (USD Billion)

7.4.5. India


7.4.5.1. India myocardial infarction treatment market revenue, by Product type, 2014 2022 (USD Billion)

7.4.5.2. India myocardial infarction treatment market revenue, by Distribution channel, 2014 2022 (USD Billion)

7.5. Latin America


7.5.1. Latin America myocardial infarction treatment market revenue, by Product type, 2014 2022 (USD Billion)

7.5.2. Latin America myocardial infarction treatment market revenue, by Distribution channel, 2014 2022 (USD Billion)

7.5.3. Brazil


7.5.3.1. Brazil myocardial infarction treatment market revenue, by Product type, 2014 2022 (USD Billion)

7.5.3.2. Brazil myocardial infarction treatment market revenue, by Distribution channel, 2014 2022 (USD Billion)

7.6. Middle East and Africa


7.6.1. Middle East and Africa myocardial infarction treatment market revenue, by Product type, 2014 2022 (USD Billion)

7.6.2. Middle East and Africa myocardial infarction treatment market revenue, by Distribution channel, 2014 2022 (USD Billion)

Chapter 8. Company Profile


8.1. Bayer


8.1.1. Overview

8.1.2. Financials

8.1.3. Therapy portfolio

8.1.4. Business strategy

8.1.5. Recent developments

8.2. Novartis


8.2.1. Overview

8.2.2. Financials

8.2.3. Therapy portfolio

8.2.4. Business strategy

8.2.5. Recent developments

8.3. Daiichi Sankyo Company Limited


8.3.1. Overview

8.3.2. Financials

8.3.3. Therapy portfolio

8.3.4. Business strategy

8.3.5. Recent developments

8.4. Boehringer Ingelheim GmbH


8.4.1. Overview

8.4.2. Financials

8.4.3. Therapy portfolio

8.4.4. Business strategy

8.4.5. Recent developments

8.5. Sandoz


8.5.1. Overview

8.5.2. Financials

8.5.3. Therapy portfolio

8.5.4. Business strategy

8.5.5. Recent developments

8.6. Astrazeneca


8.6.1. Overview

8.6.2. Financials

8.6.3. Therapy portfolio

8.6.4. Business strategy

8.6.5. Recent developments

8.7. Janssen Biotech, Inc.


8.7.1. Overview

8.7.2. Financials

8.7.3. Therapy portfolio

8.7.4. Business strategy

8.7.5. Recent developments

8.8. Merck Co. Inc.


8.8.1. Overview

8.8.2. Financials

8.8.3. Therapy portfolio

8.8.4. Business strategy

8.8.5. Recent developments

8.9. Sanofi


8.9.1. Overview

8.9.2. Financials

8.9.3. Therapy portfolio

8.9.4. Business strategy

8.9.5. Recent developments

8.10. Pfizer Inc.


8.10.1. Overview

8.10.2. Financials

8.10.3. Therapy portfolio

8.10.4. Business strategy

8.10.5. Recent developments